pharmacokinetics of glp-1 receptor agonists A Comprehensive Review on the and Drug−Drug Interactions Approved and a Dual GLP-1/GIP Receptor Agonist GLP-1 and the kidney: from

They follow what they hear

The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease

Only one of those is GLP-1

The FDA has laid out post-marketing safety testing requirements for Lilly's weight-loss pill Foundayo, including clinical trials.

NOT YOUR ORDINARY FIBER: The secret to Supergut is a powerful prebiotic fiber called Resistant Starch

GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health